BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17214026)

  • 1. Pressure gradient response after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Veselka J
    Kardiol Pol; 2006 Oct; 64(10):1161-2; author reply 1162. PubMed ID: 17214026
    [No Abstract]   [Full Text] [Related]  

  • 2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation.
    Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE
    Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
    Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
    Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
    Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
    Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alcohol ablation of the interventricular septum in a patient with hypertrophic obstructive cardiomyopathy complicated by an increase in the pressure gradient in the left ventricular outflow tract. A case report].
    Płazak W; Podolec P; Krochin M; Gackowski A; Pieniazek P; Kapelak B; Sadowski J; Tracz W
    Kardiol Pol; 2006 Sep; 64(9):989-93. PubMed ID: 17054031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography.
    Breithardt OA; Stolle B; Franke A; Janssens U; Hanrath P; Kuhn H
    Z Kardiol; 2003 Dec; 92(12):1003-7. PubMed ID: 14663610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.
    Sitges M; Shiota T; Lever HM; Qin JX; Bauer F; Drinko JK; Agler DA; Martin MG; Greenberg NL; Smedira NG; Lytle BW; Tuzcu EM; Garcia MJ; Thomas JD
    Am J Cardiol; 2003 Apr; 91(7):817-21. PubMed ID: 12667567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings.
    Yacoub MH
    Circulation; 2005 Jul; 112(4):450-2. PubMed ID: 16043655
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report.
    Tengiz I; Ercan E; Alioglu E; Turk UO
    BMC Cardiovasc Disord; 2006 Apr; 6():15. PubMed ID: 16606458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
    Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
    Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in cardiovascular medicine. Epicardial real-time 3-dimensional echocardiography during septal myectomy for obstructive hypertrophic cardiomyopathy.
    Nash PJ; Agler DA; Shin JH; Qin J; Smedira NG; Lever HM; Shiota T; Thomas JD
    Circulation; 2003 Aug; 108(8):e54-5. PubMed ID: 12939245
    [No Abstract]   [Full Text] [Related]  

  • 16. Echocardiography-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Hsieh TC; Patel K
    Anesth Analg; 2011 Jul; 113(1):44-6. PubMed ID: 21519056
    [No Abstract]   [Full Text] [Related]  

  • 17. Alcohol septal ablation after failed surgical myectomy.
    Joyal D; Arab D; Chen-Johnston C; Leya F
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):999-1002. PubMed ID: 17525959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
    Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bubble Contrast Echocardiography for Alcohol Septal Ablation.
    Arias EA; Peña-Duque MA; Martínez-Ríos MA
    Rev Esp Cardiol (Engl Ed); 2019 May; 72(5):416. PubMed ID: 29784547
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.